- Investing Ideas
- Hong Kong Healthcare Undervalued based on future growth
Hong Kong Healthcare Undervalued based on future growth
Results
6
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
6 companies
Sinopharm Group
Market Cap: HK$52.2b
Engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China.
1099
HK$16.74
7D
-0.06%
1Y
-15.1%
Beijing Chunlizhengda Medical Instruments
Market Cap: HK$5.6b
Engages in the research, development, production, and sale of surgical implants, instruments, and related products in the People’s Republic of China and internationally.
1858
HK$8.67
7D
-6.1%
1Y
-45.7%
LEPU ScienTech Medical Technology (Shanghai)
Market Cap: HK$4.0b
An investment holding company, engages in the manufacture and sale of interventional treatment series occluders and heart valve medical devices.
2291
HK$11.41
7D
0.6%
1Y
-54.4%
Chaoju Eye Care Holdings
Market Cap: HK$1.8b
Owns and operates a network of ophthalmic hospitals and centers in the People’s Republic of China.
2219
HK$2.55
7D
-2.1%
1Y
-16.0%
Yonghe Medical Group
Market Cap: HK$1.3b
Provides hair-related healthcare services in China.
2279
HK$2.51
7D
1.6%
1Y
-13.6%
Sisram Medical
Market Cap: HK$1.0b
Engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home-use devices, injectables, and cosmeceutical products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America.
1696
HK$2.17
7D
-3.1%
1Y
-69.0%